Alteogen Inc.: South Korea Biotech Stock Plunges—Can It Restore Investor Confidence?
Alteogen Inc. faces soaring P/E and volatile prices, risking investor trust. Discover why its biotech ambitions may not justify its high valuation.
2 minutes to read